Grant: Canada Postdoctoral Research Award (CPRA) program
Direct Payment
$140,000.00
SARM1 Links Mechanical Stress to Ferroptotic Vulnerability After Intracerebral Hemorrhage
EF 2025-26
Résumé
A brain bleed, or intracerebral hemorrhage (ICH), is one of the deadliest types of stroke. It occurs when a blood vessel bursts inside the brain. Although ICH causes nearly half of all stroke-related death and disability, there are still no protective treatments. Recovery depends heavily on the health of the brain's "wiring," made up of bundles of nerve fibers called white matter tracts. One of the most important of these, the corticospinal tract (CST), controls our ability to move. Unfortunately, the CST runs directly through the regions where most bleeds occur. In the first few hours after ICH, the expanding bleed squeezes surrounding tissue, stretching and deforming nearby white matter tracts and nerve fibres. This "first hit" can weaken the CST, leaving it more vulnerable. About a day later, the clot begins to break down, releasing iron and toxic molecules that trigger ferroptosis: an iron-driven form of cell death that happens when cells run out of their natural antioxidant defenses. The missing piece is the cellular "switch" that links these two phases of damage.
My project focuses on a key molecule called SARM1. Normally inactive, SARM1 switches on when nerve fibers are under stress. Once active, it behaves like a stuck breaker switch that drains the cell's battery, leaving it too depleted to fight off toxic damage. My early results show that mechanical stress alone can flip this switch, and that mice without SARM1 are protected after ICH. By combining engineered 3D brain cultures ("tissue in a dish") with advanced mouse ICH models, I will test if SARM1 is the missing link between early mechanical stress and later ferroptotic damage. This work could help define the critical time window when treatments should block SARM1 after ICH. As drugs that target SARM1 are already in development, clarifying how to best use them could bring us closer to the first treatment that protects the brain after a bleed.
Programme
Canada Postdoctoral Research Award (CPRA) program
Bénéficiaire
Emplacement
New York, United States of America
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
537156
Name
Kalisvaart Anna C
Region
New York
Country
United States of America
Orgtype
Research Institution
Instname2
Neurosciences, Mental Health and Addiction
Theme2
Biomedical
Prcname2
Canada Postdoctoral Research Award - A
Projecttitle
SARM1 Links Mechanical Stress to Ferroptotic Vulnerability After Intracerebral Hemorrhage
Programtype2
Fellowship Programs
Orgnameinp2
Direct Payment
Cihramount2
$140,000
Cihrequipment2
$0
Programname2
Canada Postdoctoral Research Award (CPRA) program
Keyworddelim
Corticospinal Tract; Ferroptosis; Intracerebral Hemorrhage (Ich); Intracranial Pressure (Icp); Mechanotransduction; Nad+ Metabolism; Neuroprotection; Sarm1 (Sterile Alpha And Tir Motif-Containing Protein 1); Stroke; White Matter Injury
Abstract
A brain bleed, or intracerebral hemorrhage (ICH), is one of the deadliest types of stroke. It occurs when a blood vessel bursts inside the brain. Although ICH causes nearly half of all stroke-related death and disability, there are still no protective treatments. Recovery depends heavily on the health of the brain's "wiring," made up of bundles of nerve fibers called white matter tracts. One of the most important of these, the corticospinal tract (CST), controls our ability to move. Unfortunately, the CST runs directly through the regions where most bleeds occur. In the first few hours after ICH, the expanding bleed squeezes surrounding tissue, stretching and deforming nearby white matter tracts and nerve fibres. This "first hit" can weaken the CST, leaving it more vulnerable. About a day later, the clot begins to break down, releasing iron and toxic molecules that trigger ferroptosis: an iron-driven form of cell death that happens when cells run out of their natural antioxidant defenses. The missing piece is the cellular "switch" that links these two phases of damage.
My project focuses on a key molecule called SARM1. Normally inactive, SARM1 switches on when nerve fibers are under stress. Once active, it behaves like a stuck breaker switch that drains the cell's battery, leaving it too depleted to fight off toxic damage. My early results show that mechanical stress alone can flip this switch, and that mice without SARM1 are protected after ICH. By combining engineered 3D brain cultures ("tissue in a dish") with advanced mouse ICH models, I will test if SARM1 is the missing link between early mechanical stress and later ferroptotic damage. This work could help define the critical time window when treatments should block SARM1 after ICH. As drugs that target SARM1 are already in development, clarifying how to best use them could bring us closer to the first treatment that protects the brain after a bleed.
Competitiondate
202509
Approvedterm2
2 yrs 0 mth
Pinamesdelim
Kalisvaart, Anna C
Approvedterm
2 ans 0 mois
Cihrcontribution2
~ $140,000~ $0~